Investor Relations

English Español Português Deutsch

Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022

View Press Release View All

Nov 16, 2022 • 8:00 AM EST

Khiron begins sales in Switzerland and expands its medical cannabis portfolio in Germany and the United Kingdom

Sep 13, 2022 • 11:48 AM EDT

Khiron Life Sciences Awarded Best Latin American Cannabis Company at Benzinga Cannabis Capital Conference

Sep 1, 2022 • 9:20 AM EDT

Khiron, the Global Leader in Medical Cannabis Launches New Cannabis Products in Europe including Stellar Genetics from California

View Presentation

Upcoming Event

Nov 30, 2022 • 11:00 am EST

Q3 2022 - Financial Statements Call

View Event Add to Calendar

View All

Latest Financial Results

Q2 2022

Quarter Ended Jun 30, 2022

Earnings Release

PDF WEB

Audio

Earnings Webcast

Financial Statements

PDF

MD&A

PDF

Company Overview

Khiron Life Sciences (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMXC) is a vertically integrated global medical and CPG cannabis leader with core operations in Latin America and Europe. We currently have distribution throughout various countries in Latin America, along with activity in North America and Europe. The company is licensed in Colombia for the cultivation, production, domestic distribution, and international export of both low and high THC medical cannabis products from Colombia to UK, Peru and Uruguay/Brazil.

View Management Team View Board of Directors

Investor Contact Information

Company

Khiron Life Sciences Corp.
100 King Street West
Suite 1600
Toronto, Ontario M5X 1A9
Canada